FAQs on COVID-19 Vaccination with U.S. Surgeon General Vivek Murthy

“We know rural areas are different from urban areas, people are more spread out, it's not always as easy to travel to one location that's close to everyone to get a vaccine. So we've got to work through some of those logistical barriers," Dr. Murthy says.
“We know rural areas are different from urban areas, people are more spread out, it's not always as easy to travel to one location that's close to everyone to get a vaccine. So we've got to work through some of those logistical barriers," Dr. Murthy says.
(United States Department of Health and Human Services )

To answer common questions about the COVID-19 vaccine, U.S. Surgeon General vice admiral Dr. Vivek Murthy joined AgriTalk on May 4. This was the same day President Joe Biden shared the goal for 70% of adults in America to have had at least one shot of the vaccine by July 4.

“The progress report is good,” Murthy says. “We have made tremendous progress in vaccinating the country to date. If you look at people above the age of 65, we've gotten at least one dose of the vaccine into more than 80%, which is pretty extraordinary. And we have about 70% of our seniors who are now fully vaccinated.”

But even with those 150 million people who have had at least one shot, Murthy says the country needs to have another 100 million shots administered in the next 60 days to reach the president’s next goal by July 4. 

You can listen to the full interview with Murthy here: 

On the segment, Murthy answered several commonly asked questions about the COVID-19 vaccine:

Do we have enough supply? 

“Here in America, we have done a good job of bolstering our supply. So we do have more and more vaccine available for those who want it. And we also, very importantly, have more places where you can get a vaccine.”

What is being done to increase access to the vaccine? 

“There are over 40,000 pharmacies in the country that now have vaccine to offer. We have community vaccination sites, we have community health centers where we've actually directly delivered vaccine from the federal government and we've got more primary care doctors who are getting vaccine direct-ly in their offices so they can give it to patients. The President and the administration will be providing more direct funding and support to rural health clinics to support outreach as well as direct allocation of vaccine to rural health clinics so they can directly vaccinate their own patients.”

How is access being improved specifically to rural America? 

“We know rural areas are different from urban areas, people are more spread out, it's not always as easy to travel to one location that's close to everyone to get a vaccine. So we've got to work through some of those logistical barriers, which is why the funding for the rural health clinics and for these mobile units is so important. But we also know everyone looked gets information from different sources. We're a big country. Not everyone listens to the same news station, radio station and that means we've got to do more work in getting information out, and particularly through people's doctors, which is the reason behind one of the projects we launched. From my office and other offices in the government it’s something called COVID-19 Community Core, where we bring together doctors, nurses, faith leaders, local business leaders and others to get the accurate information they know they and their communities want and to be able to share that with them. 

In addition to people trusting the doctors and nurses who take care of them, we know about 50% of people say they would take the advice of a family member or friend when it comes to making a decision on the vaccine. What that means is even if you don't have a medical degree or a nursing degree, you can still be a vital force in helping people understand the vaccines we have for COVID-19 are a way to protect them against COVID and a way, ultimately, for us to help turn this pandemic around.”

Why are people hesitant to get the vaccine? 

“We've seen a lot of news stories about people being hesitant to get the vaccine. But what we're finding actually is people who haven't gotten vaccinated yet it's a combination of a few things. Some people have questions, which are important to answer. We want people to get answers from reliable sources, like their doctors or their nurses who take care of them. But we also know some people are wondering if it's really that important for them to get vaccinated. Maybe they're young and healthy, and they think, ‘Hey, I'm not at high risk of a bad outcome, do I really need to get this vaccine?’, or maybe they're working two or three jobs and don't have transportation to get to a vaccine center. 

We’re trying to work on all three fronts to make sure we're working closely with doctors and nurses around the country, as well as pastors and other faith leaders, to help get information to their com-munities. But we're also trying to improve the number of access points so it's easier and easier hope-fully over the weeks ahead for people to get vaccines in their pharmacy, in their doctor's office or in their neighborhoods.”

Should people who have had COVID-19 get vaccinated? 

“The answer is yes. And here's why. It turns out the immunity you get from a natural infection is actually not as robust. It's not as strong as the protection you get from the vaccine. So you're more likely to be at risk for reinfection. That's why we're asking everyone to get vaccinated regardless of their prior infection.”

What if people still have questions? 

“I always say our health is personal to us. And if you have questions, you absolutely have a right to get those questions answered because ultimately, it's your health. Here are a couple of things to keep in mind about the vaccine. 

  1. Recognize 90% of doctors in this country have either gotten the vaccine or are planning to get it as soon as possible. That tells you about the faith the medical profession has in the vaccine. 
  2. Keep in mind these vaccines, even though it seems like they were developed on a quick timeframe, the technology behind them has been in development for decades. 
  3. We are lucky enough to see the culmination of that research, and these vaccines have been studied rigorously in clinical trials and what we've seen with nearly 150 million people having received at least one dose of the vaccine is this side effect profile remains really strong in terms of safety. The effectiveness remains extraordinarily strong and high as well. That's what you want to see — high effectiveness and very low risk in any vaccine you take.  
  4. I know many people are worried about the side effects of the vaccine. But first of all, the vast majority of people don't have side effects from this vaccine. Those who do tend to experience one to two days of flu-like symptoms, meaning fatigue, maybe a low-grade fever and a body ache, but that lasts for about a day or two. Then it goes away, and they feel pretty good. Afterward what you're left with is protection from the vaccine. 

“It's certainly a blessing to be able to serve the country, especially at a time like this during this pandemic crisis. I'm eager to do everything I can to help,” Murthy says. 
 

 

Latest News

Oil Testing Offers Value: Like a Blood Test for Tractors and Combines
Oil Testing Offers Value: Like a Blood Test for Tractors and Combines

Oil and fluid testing answers both short- and long-term questions about the internal condition of engines, transmissions and hydraulic systems.

Airplane
Still Waiting on SAF Announcement

While the White House aims to boost production of SAF, it has faced challenges in defining rules for tax credits, particularly for crop-based forms of the fuel.

Corn Prices Higher After USDA's Bullish Reports, Soybeans Flat: Where Do the Markets go Now?
Corn Prices Higher After USDA's Bullish Reports, Soybeans Flat: Where Do the Markets go Now?

Grains end mixed with strong gains in corn in reaction to USDA's 90 million acre estimate and lower than expected stocks. But how much higher can corn go? Garrett Toay, AgTraderTalk, shares his thoughts.

Where Did All the Corn Acres and Principal Crop Acres Go? The Two Biggest Questions from USDA's Big Prospective Plantings Report
Where Did All the Corn Acres and Principal Crop Acres Go? The Two Biggest Questions from USDA's Big Prospective Plantings Report

USDA says farmers intend to plant 90 million acres of corn this year, which is lower than the trade expected prior to USDA's big Prospective Plantings report.

USDA Shocks the Markets with 90 Million Corn Acre Estimate:  Where do Corn and Soybean Prices Go From Here?
USDA Shocks the Markets with 90 Million Corn Acre Estimate: Where do Corn and Soybean Prices Go From Here?

USDA provides bullish reports for corn, but neutral to bearish for soybeans and wheat. Brian Splitt, AgMarket.Net, has details.

APHIS Now Thinks Wild Birds Are to Blame for Highly Pathogenic Avian Influenza's Arrival on Four U.S. Dairies
APHIS Now Thinks Wild Birds Are to Blame for Highly Pathogenic Avian Influenza's Arrival on Four U.S. Dairies

The livestock industry continues to grapple with the first confirmed cases of HPAI in cattle, while federal and state agencies continue to assure consumers there's no concern about the safety of the U.S. milk supply.